Resolution of Advanced Conjunctival Squamous Cell Carcinoma with Cemiplimab Immunotherapy, IFNα-2b, and Retinoic Acid Treatment Over 2 Years of Follow-Up
April 2024
in “
Canadian Journal of Ophthalmology
”
TLDR A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.
A 62-year-old female with advanced conjunctival squamous cell carcinoma achieved complete remission over 2 years using cemiplimab immunotherapy, topical IFNα-2b, and retinoic acid, despite declining surgery. The treatment was effective with minimal side effects, though it caused persistent eyelash and eyebrow hair loss. This case underscores the potential of these therapies in managing advanced conjunctival SCC and suggests further research into immunotherapy's role in such conditions.
